Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 106INDUSTRY 36NIH 9OTHER_GOV 5NETWORK 5FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1

Conditions

Prostatic Neoplasms 53Neoplasms 8Urinary Bladder Neoplasms 4Neoplasm Metastasis 4Urinary Incontinence 3Erectile Dysfunction 3Pulmonary Disease, Chronic Obstructive 2Non-Muscle Invasive Bladder Neoplasms 2Lung Neoplasms 2Kidney Failure, Chronic 2Heart Failure 2Dementia 2Breast Neoplasms 2Weight Loss 1Urogenital Neoplasms 1Ureteral Neoplasms 1Turcot syndrome 1Recurrence 1Prostatic Neoplasms, Castration-Resistant 1Prostatic Diseases 1Prostate cancer, familial 1Prostate Cancer Prevention 1Prostate Cancer Diagnosis 1Patients With Prostate Cancer 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Obesity 1Newly Diagnosed Oligometastatic Prostate Cancer 1Neoplasms by Site 1Motor Activity 1Male Urogenital Diseases 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Recurrence × Genitourinary × Clear all
NCT00018538 2009-01-21

Calcifidol Therapy in Men With Cancer

VA Office of Research and Development

Phase 2 Completed
Genitourinary

Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡